MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

Search

Alcon Inc

Aperta

SettoreSettore sanitario

81.69 0.41

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

80.77

Massimo

81.94

Metriche Chiave

By Trading Economics

Entrata

55M

238M

Vendite

18M

2.6B

P/E

Media del settore

37.619

89.037

Rendimento da dividendi

0.42

Margine di Profitto

9.11

Dipendenti

25,000

EBITDA

415M

665M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+15.72% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.42%

2.18%

Utili prossimi

24 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

2.2B

39B

Apertura precedente

81.28

Chiusura precedente

81.69

Notizie sul Sentiment di mercato

By Acuity

25%

75%

66 / 360 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Alcon Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

6 gen 2026, 15:11 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9 dic 2025, 18:51 UTC

Acquisizioni, Fusioni, Takeovers

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 dic 2025, 15:54 UTC

I principali Market Mover
Acquisizioni, Fusioni, Takeovers

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9 dic 2025, 14:32 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Upgrades Offer Price for Staar Surgical

12 nov 2025, 09:09 UTC

Utili
I principali Market Mover

Alcon Shares in Switzerland Climb After Guidance Confirmation

7 gen 2026, 01:00 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6 gen 2026, 22:03 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 gen 2026, 22:03 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 gen 2026, 15:21 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6 gen 2026, 14:56 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6 gen 2026, 14:14 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6 gen 2026, 14:14 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6 gen 2026, 14:14 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6 gen 2026, 14:13 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9 dic 2025, 14:17 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Ups Offer Price for Staar Surgical

9 dic 2025, 13:34 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9 dic 2025, 13:33 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9 dic 2025, 13:33 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9 dic 2025, 13:33 UTC

Acquisizioni, Fusioni, Takeovers

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

9 dic 2025, 13:32 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: "Go-shop" Window Expired on Dec 6 >ALC.EB

9 dic 2025, 13:32 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Transaction Now Represents Total Equity Value of About $1.6B >ALC

9 dic 2025, 13:31 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC

9 dic 2025, 13:31 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Announces Amended Merger Agreement With STAAR Surgical

9 dic 2025, 13:31 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Enters Amended Merger Agreement for Acquisition of STAAR Surgical >ALC

12 nov 2025, 08:46 UTC

Discorsi di Mercato

Alcon's Guidance Reiteration Offers Relief -- Market Talk

11 nov 2025, 21:35 UTC

Utili

Alcon 3Q Adj EPS 79c >ALC

11 nov 2025, 21:35 UTC

Utili

Alcon 3Q Rev $2.61B >ALC.EB

11 nov 2025, 21:35 UTC

Utili

Alcon Backs 2025 EPS $3.05-EPS $3.15 >ALC.EB

11 nov 2025, 21:35 UTC

Utili

Alcon 3Q EPS 48c >ALC.EB

11 nov 2025, 21:34 UTC

Utili

Alcon Backs 2025 Adj EPS $3.05-Adj EPS $3.15 >ALC

Confronto tra pari

Modifica del prezzo

Alcon Inc Previsione

Obiettivo di Prezzo

By TipRanks

15.72% in crescita

Previsioni per 12 mesi

Media 91.49 USD  15.72%

Alto 112.534 USD

Basso 75.023 USD

Basato su 12 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Alcon Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

12 ratings

7

Acquista

4

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

95.77 / 97.61Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Strong Bullish Evidence

Sentiment

By Acuity

66 / 360 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat